Literature DB >> 1639487

Induction of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by Pseudomonas aeruginosa and exotoxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma interferon, and IL-1 production in human leukocytes.

R E Staugas1, D P Harvey, A Ferrante, M Nandoskar, A C Allison.   

Abstract

Pseudomonas aeruginosa is a dominant pathogen in infection in cystic fibrosis. This bacterium is thought to play a major role in the chronic bronchial infection-induced pathophysiology. Our data showed that whole formalin-fixed heat-killed P. aeruginosa was mitogenic for human lymphocytes and induced production of substantial amounts of tumor necrosis factor alpha (TNF) in peripheral blood mononuclear leukocytes in cultures. Significant amounts of TNF were produced at 10(3) bacteria per 2 x 10(5) mononuclear leukocytes. Treatment of P. aeruginosa with polymixin B did not affect its ability to stimulate TNF production, suggesting that bacterial lipopolysaccharide is not involved. P. aeruginosa, however, did not stimulate production of the T-cell lymphokine lymphotoxin (TNF beta). Exotoxin A, considered to be an important virulence factor produced by P. aeruginosa, did not stimulate either lymphoproliferation or production of TNF. In fact, this toxin, at nontoxic concentrations, was found to depress lymphoproliferation induced by phytohemagglutinin and Staphylococcus aureus and decreased production of TNF, lymphotoxin, and gamma interferon in either lymphocytes or macrophages. This toxin similarly inhibited the production of interleukin-1 beta (IL-1 beta) and IL-1 alpha, but for the inhibition of the latter, 25-fold-less toxin was required than for inhibition of the former. Inhibition of production of TNF was as sensitive as the IL-1 alpha to exotoxin A. The effects of exotoxin A on lymphoproliferation and cytokine production could be neutralized by the addition of anti-exotoxin A antibodies. These results suggest that two mechanisms by which P. aeruginosa could contribute to the chronic bronchial infection-induced pathophysiology are the nonspecific stimulation of TNF and IL-1 and the release of exotoxin A, a toxin which depresses immune responses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639487      PMCID: PMC257297          DOI: 10.1128/iai.60.8.3162-3168.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  37 in total

1.  Toxin inhibitors of protein synthesis: production, purification, and assay of Pseudomonas aeruginosa toxin A.

Authors:  B H Iglewski; J C Sadoff
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

Review 2.  Lung disease in cystic fibrosis--an updated concept.

Authors:  M S Zach
Journal:  Pediatr Pulmonol       Date:  1990

3.  Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.

Authors:  J D Klinger; D C Straus; C B Hilton; J A Bass
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

4.  Lymphocyte responsiveness to Pseudomonas aeruginosa in cystic fibrosis: Relationship to status of pulmonary disease in sibling pairs.

Authors:  R U Sorensen; R C Stern; S H Polmar
Journal:  J Pediatr       Date:  1978-08       Impact factor: 4.406

5.  Large-scale purification and characterization of the exotoxin of Pseudomonas aeruginosa.

Authors:  S H Leppla
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

6.  Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the Hypaque-Ficoll method.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

7.  Toxicity of Pseudomonas aeruginosa exotoxin A for human macrophages.

Authors:  M Pollack; S E Anderson
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

8.  B-lymphocyte function in cystic fibrosis.

Authors:  R U Sorensen; O Ruuskanen; K Miller; R C Stern
Journal:  Eur J Respir Dis       Date:  1983-10

9.  Induction of interleukin-1 from murine peritoneal macrophages by Pseudomonas aeruginosa exotoxin A.

Authors:  M L Misfeldt; P K Legaard; S E Howell; M H Fornella; R D LeGrand
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.609

10.  Alteration of murine immune response by Pseudomonas aeruginosa exotoxin A.

Authors:  P S Holt; M L Misfeldt
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.609

View more
  15 in total

1.  Regulation of CRIg expression and phagocytosis in human macrophages by arachidonate, dexamethasone, and cytokines.

Authors:  Nick N Gorgani; Umaporn Thathaisong; Violet R S Mukaro; Ornnuthchar Poungpair; Amanda Tirimacco; Charles S T Hii; Antonio Ferrante
Journal:  Am J Pathol       Date:  2011-07-08       Impact factor: 4.307

Review 2.  Bacterial perturbation of cytokine networks.

Authors:  M Wilson; R Seymour; B Henderson
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice.

Authors:  J A Hobden; S A Masinick; R P Barrett; L D Hazlett
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes.

Authors:  E Caron; T Peyrard; S Köhler; S Cabane; J P Liautard; J Dornand
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

5.  Induction and suppression of cytokine release (tumour necrosis factor-alpha; interleukin-6, interleukin-1 beta) by Escherichia coli pathogenicity factors (adhesions, alpha-haemolysin).

Authors:  B König; W König
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

6.  Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung.

Authors:  Rishi Pabary; Charanjit Singh; Sandra Morales; Andrew Bush; Khalid Alshafi; Diana Bilton; Eric W F W Alton; Anthony Smithyman; Jane C Davies
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

Review 7.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

8.  Pseudomonas aeruginosa slime glycolipoprotein is a potent stimulant of tumor necrosis factor alpha gene expression and activation of transcription activators nuclear factor kappa B and activator protein 1 in human monocytes.

Authors:  George Lagoumintzis; Myrto Christofidou; George Dimitracopoulos; Fotini Paliogianni
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Burkholderia (basonym Pseudomonas) cepacia binding to lipid receptors.

Authors:  F A Sylvester; U S Sajjan; J F Forstner
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

10.  Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes.

Authors:  C H Mody; D E Buser; R M Syme; D E Woods
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.